1. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164:1885–1889.
Article
2. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000; 84:110–116.
Article
3. Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol. 1992; 36:452–457.
4. Lee SY, Lee HG, Kim DS, Kim JG, Chung H, Yoon YH. Ocular sarcoidosis in a Korean population. J Korean Med Sci. 2009; 24:413–419.
Article
5. Pathanapitoon K, Goossens JHM, van Tilborg TC, Kunavisarut P, Choovuthayakorn J, Rothova A. Ocular sarcoidosis in Thailand. Eye (Lond). 2010; 24:1669–1674.
Article
6. Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007; 51:41–44.
Article
7. Sharma OP. Sarcoidosis Around the World. Clin Chest Med. 2008; 29:357–363.
Article
8. Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol. 1961; 45:461–481.
Article
9. Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015; 36:669–683.
Article
10. Myers TD, Smith JR, Lauer AK, Rosenbaum JT. Iris nodules associated with infectious uveitis. Br J Ophthalmol. 2002; 86:969–974.
Article
11. Fardeau C, Champion E, Massamba N, LeHoang P. Uveitic macular edema. Eye (Lond). 2016; Forthcoming.
Article
12. BenEzra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P. Uveitis scoring system. Uveitis Scoring System. Berlin: Heidelberg: Springer;1991. p. 1–13.
13. Letocha CE, Shields JA, Goldberg RE. Retinal changes in sarcoidosis. Can J Ophthalmol. 1975; 10:184–192.
14. Goldberg NR, Jabs DA, Busingye J. Optical Coherence Tomography Imaging of Presumed Sarcoid Retinal and Optic Nerve Nodules. Ocul Immunol Inflamm. 2016; 24:293–296.
Article
15. Frohman LP, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuroophthalmol. 2001; 21:132–137.
Article
16. Adema AY, ten Kate RW, Plaisier MB. Central retinal vein occlusion as an uncommon complication of sarcoidosis. Neth J Med. 2013; 71:134–136.
17. Paović J, Paović P, Vukosavljević M. Clinical and immunological features of retinal vasculitis in systemic diseases. Vojnosanit Pregl. 2009; 66:961–965.
Article
18. Momtchilova M, Pelosse B, Ngoma E, Laroche L. Branch retinal vein occlusion and sarcoidosis in a child: a case report. J Fr Ophtalmol. 2011; 34:243–247.
19. Nichols CW, Eagle RC, Yanoff M, Menocal NG. Conjunctival biopsy as an aid in the evaluation of the patient with suspected sarcoidosis. Ophthalmology. 1980; 87:287–291.
Article
20. Karcioglu ZA, Brear R. Conjunctival biopsy in sarcoidosis. Am J Ophthalmol. 1985; 99:68–73.
Article
21. Phillips YL, Eggenberger ER. Neuro-ophthalmic sarcoidosis. Curr Opin Ophthalmol. 2010; 21:423–429.
Article
22. Mansour AM. Ocular manifestations of various systemic diseases. Curr Opin Ophthalmol. 1996; 7:96–98.
Article
23. Nishida Y, Tian S, Isberg B, Tallstedt L, Lennerstrand G. MRI measurements of orbital tissues in dysthyroid ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2001; 239:824–831.
Article
24. Demirci H, Christianson MD. Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol. 2011; 151:1074–1080.e1.
Article
25. So WL, Hardy TG, McKelvie P. Atypical Clinical Presentation of Isolated Extraocular Muscle Sarcoid. Case Rep Ophthalmol Med. 2012; 2012:370258.
Article
26. Herbort CP, Rao NA, Mochizuki M. members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009; 17:160–169.
Article
27. Nan K, Sun S, Li Y, Qu J, Li G, Luo L, Chen H, et al. Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection. Br J Ophthalmol. 2010; 94:654–658.
Article
28. Arcinue CA, Cerón OM, Foster CS. A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in Uveitis. J Ocul Pharmacol Ther. 2013; 29:501–507.
Article
29. Pascual-Camps I, Hernández-Martínez P, Monje-Fernández L, Dolz-Marco R, Gallego-Pinazo R, Wu L, et al. Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders. J Ophthalmic Inflamm Infect. 2014; 4:26.
Article